{"entity":"novartis","id":"ent_novartis","name":"Novartis","wikidata":"Q507154","page":"https://asof.is/record/novartis","summary":"Novartis is a Swiss-American multinational pharmaceutical corporation, headquartered in Basel.","title":null,"key_facts":[{"label":"Headquarters","value":"Basel","claim":"clm_0F722C0A09FC"},{"label":"Ticker","value":"NVS · NYSE","claim":"clm_FF3D83D13D18"}],"faq":[{"question":"Where is Novartis headquartered?","answer":"Basel."}],"as_of":null,"known_by":null,"since":null,"fact_pages":[{"predicate":"headquarters","page":"https://asof.is/record/novartis/headquarters","md":"https://asof.is/record/novartis/headquarters.md","json":"https://asof.is/v1/entities/novartis/headquarters"},{"predicate":"net_income","page":"https://asof.is/record/novartis/net_income","md":"https://asof.is/record/novartis/net_income.md","json":"https://asof.is/v1/entities/novartis/net_income"},{"predicate":"operating_income","page":"https://asof.is/record/novartis/operating_income","md":"https://asof.is/record/novartis/operating_income.md","json":"https://asof.is/v1/entities/novartis/operating_income"}],"products":[],"coverage":{"entity":"novartis","name":"Novartis","kind":"organization","sources":[{"source":"wikidata","item":"Q507154","covers":"dated statements whose reference URL is the source: leadership, ownership, names, founding, headquarters; never financial figures"},{"source":"wikidata-products","covers":"products it makes, develops or publishes, as released claims, when the release date cites a reference URL; a rotating scan, a few dozen entities a run"},{"source":"sec","cik":1114448,"ticker":"NVS","covers":"annual and quarterly figures from XBRL, registrant name, tickers and fiscal year end; officer and director changes (8-K Item 5.02) and material events (other 8-K items)"}],"holds":{"claims":59,"open":16,"retracted":0,"first":"1996-01-01","predicates":{"shares_outstanding":{"claims":8,"open":1,"kind":"fact"},"operating_income":{"claims":10,"open":1,"kind":"fact"},"total_assets":{"claims":9,"open":1,"kind":"fact"},"total_equity":{"claims":11,"open":1,"kind":"fact"},"net_income":{"claims":10,"open":1,"kind":"fact"},"headquarters":{"claims":1,"open":1,"kind":"fact"},"listed_on":{"claims":2,"open":2,"kind":"fact"},"state_of_incorporation":{"claims":1,"open":1,"kind":"identifier"},"website":{"claims":1,"open":1,"kind":"identifier"},"ticker":{"claims":2,"open":2,"kind":"identifier"},"registrant_name":{"claims":1,"open":1,"kind":"fact"},"cik":{"claims":1,"open":1,"kind":"identifier"},"fiscal_year_end":{"claims":1,"open":1,"kind":"identifier"},"sic_industry":{"claims":1,"open":1,"kind":"identifier"}}},"freshness":[{"origin":"sec","label":"SEC EDGAR filings: XBRL figures, registry fields, 8-K officer changes and events (sec_ingest.py, sec_officers.py, sec_events.py)","claims":58,"last_added":"2026-11-08","last_checked":"2026-11-08","last_verified":null},{"origin":"wikidata","label":"Wikidata statements that cite a reference URL (wikidata_ingest.py)","claims":1,"last_added":"2026-11-08","last_checked":"2026-11-08","last_verified":null}],"gaps":["ceo: none public; unknown, not absent: a claim is published only once checked against its source","posts: no official feed speaks for it (pipeline/feeds.json primary_for); what it holds comes from Wikidata, filings and other publishers' feeds"],"group":[],"group_complete":true,"rule":"sources: what the pipeline reads for this entity, from its config (pipeline/entities.json, feeds.json, sec_companies.json, huggingface_authors.json). holds: its public claims by predicate; open is held today; kind fact is what entity_state answers by default, event is for timeline. freshness, per ingest (origin): last_added is the day it last put a new claim here (first_seen_at), last_checked the day one was last checked against its source (checked_on), last_verified the day reverify.py last confirmed one against Wikidata (value_json.verified_at). Only checked claims are public, so a fact missing here is unknown, not absent. gaps: what the record does not cover for this entity, so an empty answer is not read as news."},"claims":[{"id":"clm_0705199BCCFC","predicate":"total_assets","value":"110,949,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total assets: 110,949,000,000 United States dollar\", as of 2025-12-31. Claim clm_0705199BCCFC, https://asof.is/claim/clm_0705199BCCFC, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm.","url":"https://asof.is/claim/clm_0705199BCCFC","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Assets in 20-F FY2025, filed 2026-02-04"}},{"id":"clm_13AEEBEB19A6","predicate":"operating_income","value":"17,644,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis operating income: 17,644,000,000 United States dollar\", as of 2025-12-31. Claim clm_13AEEBEB19A6, https://asof.is/claim/clm_13AEEBEB19A6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm.","url":"https://asof.is/claim/clm_13AEEBEB19A6","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2025, filed 2026-02-04"}},{"id":"clm_29E1C56666EB","predicate":"shares_outstanding","value":"1,908,151,679 shares","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis shares outstanding: 1,908,151,679 shares\", as of 2025-12-31. Claim clm_29E1C56666EB, https://asof.is/claim/clm_29E1C56666EB, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm.","url":"https://asof.is/claim/clm_29E1C56666EB","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 20-F FY2025, filed 2026-02-04"}},{"id":"clm_6DC4BBC10979","predicate":"total_equity","value":"46,549,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total equity: 46,549,000,000 United States dollar\", as of 2025-12-31. Claim clm_6DC4BBC10979, https://asof.is/claim/clm_6DC4BBC10979, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm.","url":"https://asof.is/claim/clm_6DC4BBC10979","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2025, filed 2026-02-04"}},{"id":"clm_8E9D1CC51F75","predicate":"net_income","value":"13,967,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis net income: 13,967,000,000 United States dollar\", as of 2025-12-31. Claim clm_8E9D1CC51F75, https://asof.is/claim/clm_8E9D1CC51F75, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm.","url":"https://asof.is/claim/clm_8E9D1CC51F75","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2025, filed 2026-02-04"}},{"id":"clm_2DD252AFDAA3","predicate":"operating_income","value":"14,544,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis operating income: 14,544,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_2DD252AFDAA3, https://asof.is/claim/clm_2DD252AFDAA3, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm.","url":"https://asof.is/claim/clm_2DD252AFDAA3","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_13AEEBEB19A6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2024","published_at":"2025-01-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2024, filed 2025-01-31"}},{"id":"clm_5B7C7456996A","predicate":"shares_outstanding","value":"1,975,089,248 shares","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis shares outstanding: 1,975,089,248 shares\", as of 2024-12-31 (until 2025-12-31). Claim clm_5B7C7456996A, https://asof.is/claim/clm_5B7C7456996A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm.","url":"https://asof.is/claim/clm_5B7C7456996A","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_29E1C56666EB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2024","published_at":"2025-01-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 20-F FY2024, filed 2025-01-31"}},{"id":"clm_5BF3DA7B810B","predicate":"net_income","value":"11,939,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis net income: 11,939,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_5BF3DA7B810B, https://asof.is/claim/clm_5BF3DA7B810B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm.","url":"https://asof.is/claim/clm_5BF3DA7B810B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8E9D1CC51F75","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2024","published_at":"2025-01-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2024, filed 2025-01-31"}},{"id":"clm_BCE8770D5AC4","predicate":"total_assets","value":"102,246,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total assets: 102,246,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_BCE8770D5AC4, https://asof.is/claim/clm_BCE8770D5AC4, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm.","url":"https://asof.is/claim/clm_BCE8770D5AC4","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0705199BCCFC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2024","published_at":"2025-01-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Assets in 20-F FY2024, filed 2025-01-31"}},{"id":"clm_DD45194F44A3","predicate":"total_equity","value":"44,126,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total equity: 44,126,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_DD45194F44A3, https://asof.is/claim/clm_DD45194F44A3, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm.","url":"https://asof.is/claim/clm_DD45194F44A3","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6DC4BBC10979","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2024","published_at":"2025-01-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2024, filed 2025-01-31"}},{"id":"clm_0BB5090F9540","predicate":"shares_outstanding","value":"2,044,033,986 shares","valid_from":"2023-12-31","valid_to":"2024-12-31","published":"2024-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis shares outstanding: 2,044,033,986 shares\", as of 2023-12-31 (until 2024-12-31). Claim clm_0BB5090F9540, https://asof.is/claim/clm_0BB5090F9540, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036824000004/0001370368-24-000004-index.htm.","url":"https://asof.is/claim/clm_0BB5090F9540","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5B7C7456996A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036824000004/0001370368-24-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2023","published_at":"2024-01-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 20-F FY2023, filed 2024-01-31"}},{"id":"clm_19784DB0CE70","predicate":"total_equity","value":"46,750,000,000 United States dollar","valid_from":"2023-12-31","valid_to":"2024-12-31","published":"2024-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total equity: 46,750,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_19784DB0CE70, https://asof.is/claim/clm_19784DB0CE70, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036824000004/0001370368-24-000004-index.htm.","url":"https://asof.is/claim/clm_19784DB0CE70","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DD45194F44A3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036824000004/0001370368-24-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2023","published_at":"2024-01-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2023, filed 2024-01-31"}},{"id":"clm_9235B12B85D4","predicate":"net_income","value":"14,854,000,000 United States dollar","valid_from":"2023-12-31","valid_to":"2024-12-31","published":"2024-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis net income: 14,854,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_9235B12B85D4, https://asof.is/claim/clm_9235B12B85D4, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036824000004/0001370368-24-000004-index.htm.","url":"https://asof.is/claim/clm_9235B12B85D4","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5BF3DA7B810B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036824000004/0001370368-24-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2023","published_at":"2024-01-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2023, filed 2024-01-31"}},{"id":"clm_C54C261844E4","predicate":"operating_income","value":"9,769,000,000 United States dollar","valid_from":"2023-12-31","valid_to":"2024-12-31","published":"2024-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis operating income: 9,769,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_C54C261844E4, https://asof.is/claim/clm_C54C261844E4, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036824000004/0001370368-24-000004-index.htm.","url":"https://asof.is/claim/clm_C54C261844E4","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2DD252AFDAA3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036824000004/0001370368-24-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2023","published_at":"2024-01-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2023, filed 2024-01-31"}},{"id":"clm_E47EB2D219FD","predicate":"total_assets","value":"99,945,000,000 United States dollar","valid_from":"2023-12-31","valid_to":"2024-12-31","published":"2024-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total assets: 99,945,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_E47EB2D219FD, https://asof.is/claim/clm_E47EB2D219FD, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036824000004/0001370368-24-000004-index.htm.","url":"https://asof.is/claim/clm_E47EB2D219FD","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BCE8770D5AC4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036824000004/0001370368-24-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2023","published_at":"2024-01-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Assets in 20-F FY2023, filed 2024-01-31"}},{"id":"clm_009FE98CC602","predicate":"shares_outstanding","value":"2,119,609,057 shares","valid_from":"2022-12-31","valid_to":"2023-12-31","published":"2023-02-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis shares outstanding: 2,119,609,057 shares\", as of 2022-12-31 (until 2023-12-31). Claim clm_009FE98CC602, https://asof.is/claim/clm_009FE98CC602, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036823000006/0001370368-23-000006-index.htm.","url":"https://asof.is/claim/clm_009FE98CC602","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0BB5090F9540","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036823000006/0001370368-23-000006-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2022","published_at":"2023-02-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 20-F FY2022, filed 2023-02-01"}},{"id":"clm_35A920D02D20","predicate":"total_equity","value":"59,423,000,000 United States dollar","valid_from":"2022-12-31","valid_to":"2023-12-31","published":"2023-02-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total equity: 59,423,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_35A920D02D20, https://asof.is/claim/clm_35A920D02D20, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036823000006/0001370368-23-000006-index.htm.","url":"https://asof.is/claim/clm_35A920D02D20","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_19784DB0CE70","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036823000006/0001370368-23-000006-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2022","published_at":"2023-02-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2022, filed 2023-02-01"}},{"id":"clm_5646B015C0F8","predicate":"net_income","value":"6,955,000,000 United States dollar","valid_from":"2022-12-31","valid_to":"2023-12-31","published":"2023-02-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis net income: 6,955,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_5646B015C0F8, https://asof.is/claim/clm_5646B015C0F8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036823000006/0001370368-23-000006-index.htm.","url":"https://asof.is/claim/clm_5646B015C0F8","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9235B12B85D4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036823000006/0001370368-23-000006-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2022","published_at":"2023-02-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2022, filed 2023-02-01"}},{"id":"clm_9BE780A31D35","predicate":"operating_income","value":"9,197,000,000 United States dollar","valid_from":"2022-12-31","valid_to":"2023-12-31","published":"2023-02-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis operating income: 9,197,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_9BE780A31D35, https://asof.is/claim/clm_9BE780A31D35, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036823000006/0001370368-23-000006-index.htm.","url":"https://asof.is/claim/clm_9BE780A31D35","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C54C261844E4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036823000006/0001370368-23-000006-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2022","published_at":"2023-02-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2022, filed 2023-02-01"}},{"id":"clm_BB5AD0135865","predicate":"total_assets","value":"117,453,000,000 United States dollar","valid_from":"2022-12-31","valid_to":"2023-12-31","published":"2023-02-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total assets: 117,453,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_BB5AD0135865, https://asof.is/claim/clm_BB5AD0135865, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036823000006/0001370368-23-000006-index.htm.","url":"https://asof.is/claim/clm_BB5AD0135865","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E47EB2D219FD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036823000006/0001370368-23-000006-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2022","published_at":"2023-02-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Assets in 20-F FY2022, filed 2023-02-01"}},{"id":"clm_1A520E1875F6","predicate":"net_income","value":"24,018,000,000 United States dollar","valid_from":"2021-12-31","valid_to":"2022-12-31","published":"2022-02-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis net income: 24,018,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_1A520E1875F6, https://asof.is/claim/clm_1A520E1875F6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036822000010/0001370368-22-000010-index.htm.","url":"https://asof.is/claim/clm_1A520E1875F6","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5646B015C0F8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036822000010/0001370368-22-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2021","published_at":"2022-02-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2021, filed 2022-02-02"}},{"id":"clm_70FD421198A4","predicate":"total_equity","value":"67,822,000,000 United States dollar","valid_from":"2021-12-31","valid_to":"2022-12-31","published":"2022-02-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total equity: 67,822,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_70FD421198A4, https://asof.is/claim/clm_70FD421198A4, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036822000010/0001370368-22-000010-index.htm.","url":"https://asof.is/claim/clm_70FD421198A4","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_35A920D02D20","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036822000010/0001370368-22-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2021","published_at":"2022-02-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2021, filed 2022-02-02"}},{"id":"clm_91947C0A764E","predicate":"total_assets","value":"131,795,000,000 United States dollar","valid_from":"2021-12-31","valid_to":"2022-12-31","published":"2022-02-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total assets: 131,795,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_91947C0A764E, https://asof.is/claim/clm_91947C0A764E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036822000010/0001370368-22-000010-index.htm.","url":"https://asof.is/claim/clm_91947C0A764E","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BB5AD0135865","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036822000010/0001370368-22-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2021","published_at":"2022-02-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Assets in 20-F FY2021, filed 2022-02-02"}},{"id":"clm_ADE03C9FEB28","predicate":"shares_outstanding","value":"2,234,939,948 shares","valid_from":"2021-12-31","valid_to":"2022-12-31","published":"2022-02-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis shares outstanding: 2,234,939,948 shares\", as of 2021-12-31 (until 2022-12-31). Claim clm_ADE03C9FEB28, https://asof.is/claim/clm_ADE03C9FEB28, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036822000010/0001370368-22-000010-index.htm.","url":"https://asof.is/claim/clm_ADE03C9FEB28","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_009FE98CC602","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036822000010/0001370368-22-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2021","published_at":"2022-02-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 20-F FY2021, filed 2022-02-02"}},{"id":"clm_E1378382005A","predicate":"operating_income","value":"11,689,000,000 United States dollar","valid_from":"2021-12-31","valid_to":"2022-12-31","published":"2022-02-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis operating income: 11,689,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_E1378382005A, https://asof.is/claim/clm_E1378382005A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036822000010/0001370368-22-000010-index.htm.","url":"https://asof.is/claim/clm_E1378382005A","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9BE780A31D35","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036822000010/0001370368-22-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2021","published_at":"2022-02-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2021, filed 2022-02-02"}},{"id":"clm_0BA338FA586A","predicate":"total_equity","value":"56,666,000,000 United States dollar","valid_from":"2020-12-31","valid_to":"2021-12-31","published":"2021-01-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total equity: 56,666,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_0BA338FA586A, https://asof.is/claim/clm_0BA338FA586A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036821000006/0001370368-21-000006-index.htm.","url":"https://asof.is/claim/clm_0BA338FA586A","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_70FD421198A4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036821000006/0001370368-21-000006-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2020","published_at":"2021-01-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2020, filed 2021-01-26"}},{"id":"clm_4B781197482C","predicate":"total_assets","value":"132,059,000,000 United States dollar","valid_from":"2020-12-31","valid_to":"2021-12-31","published":"2021-01-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total assets: 132,059,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_4B781197482C, https://asof.is/claim/clm_4B781197482C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036821000006/0001370368-21-000006-index.htm.","url":"https://asof.is/claim/clm_4B781197482C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_91947C0A764E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036821000006/0001370368-21-000006-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2020","published_at":"2021-01-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Assets in 20-F FY2020, filed 2021-01-26"}},{"id":"clm_ADC8AC894691","predicate":"operating_income","value":"10,152,000,000 United States dollar","valid_from":"2020-12-31","valid_to":"2021-12-31","published":"2021-01-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis operating income: 10,152,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_ADC8AC894691, https://asof.is/claim/clm_ADC8AC894691, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036821000006/0001370368-21-000006-index.htm.","url":"https://asof.is/claim/clm_ADC8AC894691","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E1378382005A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036821000006/0001370368-21-000006-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2020","published_at":"2021-01-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2020, filed 2021-01-26"}},{"id":"clm_BEA4CCA5A4E8","predicate":"net_income","value":"8,071,000,000 United States dollar","valid_from":"2020-12-31","valid_to":"2021-12-31","published":"2021-01-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis net income: 8,071,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_BEA4CCA5A4E8, https://asof.is/claim/clm_BEA4CCA5A4E8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036821000006/0001370368-21-000006-index.htm.","url":"https://asof.is/claim/clm_BEA4CCA5A4E8","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1A520E1875F6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036821000006/0001370368-21-000006-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2020","published_at":"2021-01-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2020, filed 2021-01-26"}},{"id":"clm_FA5B2A8636EB","predicate":"shares_outstanding","value":"2,256,822,048 shares","valid_from":"2020-12-31","valid_to":"2021-12-31","published":"2021-01-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis shares outstanding: 2,256,822,048 shares\", as of 2020-12-31 (until 2021-12-31). Claim clm_FA5B2A8636EB, https://asof.is/claim/clm_FA5B2A8636EB, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036821000006/0001370368-21-000006-index.htm.","url":"https://asof.is/claim/clm_FA5B2A8636EB","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_ADE03C9FEB28","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036821000006/0001370368-21-000006-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2020","published_at":"2021-01-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 20-F FY2020, filed 2021-01-26"}},{"id":"clm_0149AA2021B4","predicate":"operating_income","value":"9,086,000,000 United States dollar","valid_from":"2019-12-31","valid_to":"2020-12-31","published":"2020-01-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis operating income: 9,086,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_0149AA2021B4, https://asof.is/claim/clm_0149AA2021B4, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036820000003/0001370368-20-000003-index.htm.","url":"https://asof.is/claim/clm_0149AA2021B4","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_ADC8AC894691","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036820000003/0001370368-20-000003-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2019","published_at":"2020-01-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2019, filed 2020-01-29"}},{"id":"clm_0CBFF9ABD464","predicate":"net_income","value":"11,737,000,000 United States dollar","valid_from":"2019-12-31","valid_to":"2020-12-31","published":"2020-01-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis net income: 11,737,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_0CBFF9ABD464, https://asof.is/claim/clm_0CBFF9ABD464, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036820000003/0001370368-20-000003-index.htm.","url":"https://asof.is/claim/clm_0CBFF9ABD464","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BEA4CCA5A4E8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036820000003/0001370368-20-000003-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2019","published_at":"2020-01-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2019, filed 2020-01-29"}},{"id":"clm_36E9C60D9850","predicate":"total_equity","value":"55,551,000,000 United States dollar","valid_from":"2019-12-31","valid_to":"2020-12-31","published":"2020-01-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total equity: 55,551,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_36E9C60D9850, https://asof.is/claim/clm_36E9C60D9850, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036820000003/0001370368-20-000003-index.htm.","url":"https://asof.is/claim/clm_36E9C60D9850","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0BA338FA586A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036820000003/0001370368-20-000003-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2019","published_at":"2020-01-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2019, filed 2020-01-29"}},{"id":"clm_657C4132B151","predicate":"shares_outstanding","value":"2,265,008,488 shares","valid_from":"2019-12-31","valid_to":"2020-12-31","published":"2020-01-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis shares outstanding: 2,265,008,488 shares\", as of 2019-12-31 (until 2020-12-31). Claim clm_657C4132B151, https://asof.is/claim/clm_657C4132B151, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036820000003/0001370368-20-000003-index.htm.","url":"https://asof.is/claim/clm_657C4132B151","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FA5B2A8636EB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036820000003/0001370368-20-000003-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2019","published_at":"2020-01-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 20-F FY2019, filed 2020-01-29"}},{"id":"clm_6F1C27991C72","predicate":"total_assets","value":"118,370,000,000 United States dollar","valid_from":"2019-12-31","valid_to":"2020-12-31","published":"2020-01-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total assets: 118,370,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_6F1C27991C72, https://asof.is/claim/clm_6F1C27991C72, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036820000003/0001370368-20-000003-index.htm.","url":"https://asof.is/claim/clm_6F1C27991C72","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4B781197482C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036820000003/0001370368-20-000003-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2019","published_at":"2020-01-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Assets in 20-F FY2019, filed 2020-01-29"}},{"id":"clm_35A80D4D8E81","predicate":"shares_outstanding","value":"2,311,171,429 shares","valid_from":"2018-12-31","valid_to":"2019-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis shares outstanding: 2,311,171,429 shares\", as of 2018-12-31 (until 2019-12-31). Claim clm_35A80D4D8E81, https://asof.is/claim/clm_35A80D4D8E81, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_35A80D4D8E81","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_657C4132B151","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2018","published_at":"2019-01-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 20-F FY2018, filed 2019-01-30"}},{"id":"clm_58FF0FED75A7","predicate":"total_equity","value":"78,692,000,000 United States dollar","valid_from":"2018-12-31","valid_to":"2019-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total equity: 78,692,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_58FF0FED75A7, https://asof.is/claim/clm_58FF0FED75A7, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_58FF0FED75A7","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_36E9C60D9850","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2018","published_at":"2019-01-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2018, filed 2019-01-30"}},{"id":"clm_86476E83D754","predicate":"net_income","value":"12,614,000,000 United States dollar","valid_from":"2018-12-31","valid_to":"2019-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis net income: 12,614,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_86476E83D754, https://asof.is/claim/clm_86476E83D754, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_86476E83D754","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0CBFF9ABD464","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2018","published_at":"2019-01-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2018, filed 2019-01-30"}},{"id":"clm_967603AD607D","predicate":"total_assets","value":"145,563,000,000 United States dollar","valid_from":"2018-12-31","valid_to":"2019-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total assets: 145,563,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_967603AD607D, https://asof.is/claim/clm_967603AD607D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_967603AD607D","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6F1C27991C72","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2018","published_at":"2019-01-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Assets in 20-F FY2018, filed 2019-01-30"}},{"id":"clm_D3E230AFF547","predicate":"operating_income","value":"8,169,000,000 United States dollar","valid_from":"2018-12-31","valid_to":"2019-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis operating income: 8,169,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_D3E230AFF547, https://asof.is/claim/clm_D3E230AFF547, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_D3E230AFF547","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0149AA2021B4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2018","published_at":"2019-01-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2018, filed 2019-01-30"}},{"id":"clm_0526738C57FA","predicate":"operating_income","value":"8,629,000,000 United States dollar","valid_from":"2017-12-31","valid_to":"2018-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis operating income: 8,629,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_0526738C57FA, https://asof.is/claim/clm_0526738C57FA, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_0526738C57FA","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D3E230AFF547","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2018","published_at":"2019-01-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2018, filed 2019-01-30"}},{"id":"clm_12A2AD908EB7","predicate":"net_income","value":"7,703,000,000 United States dollar","valid_from":"2017-12-31","valid_to":"2018-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis net income: 7,703,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_12A2AD908EB7, https://asof.is/claim/clm_12A2AD908EB7, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_12A2AD908EB7","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_86476E83D754","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2018","published_at":"2019-01-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2018, filed 2019-01-30"}},{"id":"clm_1FFF878FB953","predicate":"total_equity","value":"74,227,000,000 United States dollar","valid_from":"2017-12-31","valid_to":"2018-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total equity: 74,227,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_1FFF878FB953, https://asof.is/claim/clm_1FFF878FB953, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_1FFF878FB953","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_58FF0FED75A7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2018","published_at":"2019-01-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2018, filed 2019-01-30"}},{"id":"clm_2DC7A9C81128","predicate":"total_assets","value":"133,079,000,000 United States dollar","valid_from":"2017-12-31","valid_to":"2018-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total assets: 133,079,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_2DC7A9C81128, https://asof.is/claim/clm_2DC7A9C81128, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_2DC7A9C81128","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_967603AD607D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2018","published_at":"2019-01-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Assets in 20-F FY2018, filed 2019-01-30"}},{"id":"clm_1F7255C1F465","predicate":"total_equity","value":"74,891,000,000 United States dollar","valid_from":"2016-12-31","valid_to":"2017-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total equity: 74,891,000,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_1F7255C1F465, https://asof.is/claim/clm_1F7255C1F465, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_1F7255C1F465","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1FFF878FB953","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2018","published_at":"2019-01-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2018, filed 2019-01-30"}},{"id":"clm_A450BC25D4EC","predicate":"net_income","value":"6,698,000,000 United States dollar","valid_from":"2016-12-31","valid_to":"2017-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis net income: 6,698,000,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_A450BC25D4EC, https://asof.is/claim/clm_A450BC25D4EC, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_A450BC25D4EC","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_12A2AD908EB7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2018","published_at":"2019-01-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2018, filed 2019-01-30"}},{"id":"clm_EE8DEE22E155","predicate":"operating_income","value":"8,268,000,000 United States dollar","valid_from":"2016-12-31","valid_to":"2017-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis operating income: 8,268,000,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_EE8DEE22E155, https://asof.is/claim/clm_EE8DEE22E155, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_EE8DEE22E155","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0526738C57FA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2018","published_at":"2019-01-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2018, filed 2019-01-30"}},{"id":"clm_F4A7EF9247D5","predicate":"total_equity","value":"77,122,000,000 United States dollar","valid_from":"2015-12-31","valid_to":"2016-12-31","published":"2019-01-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total equity: 77,122,000,000 United States dollar\", as of 2015-12-31 (until 2016-12-31). Claim clm_F4A7EF9247D5, https://asof.is/claim/clm_F4A7EF9247D5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.","url":"https://asof.is/claim/clm_F4A7EF9247D5","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1F7255C1F465","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2018","published_at":"2019-01-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2018, filed 2019-01-30"}},{"id":"clm_684F998583E7","predicate":"website","value":"http://www.novartis.com/","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis website: http://www.novartis.com/\", undated. Claim clm_684F998583E7, https://asof.is/claim/clm_684F998583E7, accessed 2026-11-08. Source: https://www.wikidata.org/wiki/Q507154.","url":"https://asof.is/claim/clm_684F998583E7","accessed":"2026-11-08"},"confidence":0.45,"status":"unverified","assertable":false,"why_not":"low_confidence","superseded_by":null,"sources":[{"url":"https://www.wikidata.org/wiki/Q507154","tier":"secondary","publisher":"Wikidata","published_at":null}],"evidence":{"by":"own-site","on":"2026-11-08","quote":"Novartis.","url":"https://www.novartis.com/"}},{"id":"clm_0F722C0A09FC","predicate":"headquarters","value":"Basel","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis headquarters: Basel\", undated. Claim clm_0F722C0A09FC, https://asof.is/claim/clm_0F722C0A09FC, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_0F722C0A09FC","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://textielmuseum.nl/collectie/objecten/?diw-id=brabantcloud_textielmuseum-objecten_09142a=b","tier":"secondary","publisher":null,"published_at":null},{"url":"https://www.wikidata.org/wiki/Q507154","tier":"secondary","publisher":"Wikidata","published_at":null},{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_626AF6641092","predicate":"listed_on","value":"OTC","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis listed on: OTC\", undated. Claim clm_626AF6641092, https://asof.is/claim/clm_626AF6641092, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_626AF6641092","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_64105409876F","predicate":"state_of_incorporation","value":"V8","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis state of incorporation: V8\", undated. Claim clm_64105409876F, https://asof.is/claim/clm_64105409876F, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_64105409876F","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_75D99E5C33AE","predicate":"ticker","value":"NVSEF","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis ticker: NVSEF\", undated. Claim clm_75D99E5C33AE, https://asof.is/claim/clm_75D99E5C33AE, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_75D99E5C33AE","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_9ECB34CF2487","predicate":"registrant_name","value":"NOVARTIS AG","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis registrant name: NOVARTIS AG\", undated. Claim clm_9ECB34CF2487, https://asof.is/claim/clm_9ECB34CF2487, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_9ECB34CF2487","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_A272094EA644","predicate":"listed_on","value":"NYSE","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis listed on: NYSE\", undated. Claim clm_A272094EA644, https://asof.is/claim/clm_A272094EA644, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_A272094EA644","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_B49F45CDC592","predicate":"cik","value":"0001114448","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis cik: 0001114448\", undated. Claim clm_B49F45CDC592, https://asof.is/claim/clm_B49F45CDC592, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_B49F45CDC592","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_CF6F00F357D4","predicate":"fiscal_year_end","value":"12-31","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis fiscal year end: 12-31\", undated. Claim clm_CF6F00F357D4, https://asof.is/claim/clm_CF6F00F357D4, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_CF6F00F357D4","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_F61B5ED25295","predicate":"sic_industry","value":"Pharmaceutical Preparations (2834)","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis sic industry: Pharmaceutical Preparations (2834)\", undated. Claim clm_F61B5ED25295, https://asof.is/claim/clm_F61B5ED25295, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_F61B5ED25295","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_FF3D83D13D18","predicate":"ticker","value":"NVS","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis ticker: NVS\", undated. Claim clm_FF3D83D13D18, https://asof.is/claim/clm_FF3D83D13D18, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_FF3D83D13D18","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}}],"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{"low_confidence":"Confidence below 0.5, the line the record asserts at."},"checked_by":{"sec-filing":"parsed from the SEC filing","own-site":"the entity's own site names it (a website whose page names the entity, a handle its website links to)"}}}